|
CASC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52994000000017E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.7886000000047E-05 |
| Normal-vs-Stage2 |
2.681400E-03 |
| Normal-vs-Stage3 |
4.20410000001592E-06 |
| Normal-vs-Stage4 |
1.92870999999872E-05 |
| Stage1-vs-Stage2 |
8.161600E-01 |
| Stage1-vs-Stage3 |
2.248400E-01 |
| Stage1-vs-Stage4 |
2.162800E-01 |
| Stage2-vs-Stage3 |
5.591600E-01 |
| Stage2-vs-Stage4 |
4.545400E-01 |
| Stage3-vs-Stage4 |
7.653000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00609999995361E-06 |
| Normal-vs-AfricanAmerican |
9.057800E-02 |
| Normal-vs-Asian |
4.441100E-04 |
| Caucasian-vs-AfricanAmerican |
2.080600E-01 |
| Caucasian-vs-Asian |
9.435600E-01 |
| AfricanAmerican-vs-Asian |
2.480400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21919999995779E-06 |
| Normal-vs-Female |
6.34409999999974E-05 |
| Male-vs-Female |
1.836430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.020800E-04 |
| Normal-vs-Age(41-60Yrs) |
6.21859999999641E-05 |
| Normal-vs-Age(61-80Yrs) |
1.54910000005337E-06 |
| Normal-vs-Age(81-100Yrs) |
1.806250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.544000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.472970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.185600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.131400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.679200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.063600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.277570E-01 |
| Classical-VS-Follicular |
1.291790E-01 |
| Classical-VS-Other |
2.604200E-01 |
| Classical-VS-Normal |
3.180000E-04 |
| Tall-VS-Follicular |
6.119200E-01 |
| Tall-VS-Other |
7.075800E-01 |
| Tall-VS-Normal |
1.837330E-04 |
| Follicular-VS-Other |
5.898800E-01 |
| Follicular-VS-Normal |
1.369650E-04 |
| Other-VS-Normal |
1.607560E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46399999999092E-05 |
| Normal-vs-N1 |
3.15070000000972E-06 |
| N0-vs-N1 |
2.869400E-01 |
|
|
